Singapore markets open in 4 hours 52 minutes

Interpace Biosciences, Inc. (IDXG)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.4300-0.0200 (-1.38%)
At close: 03:48PM EDT
Full screen
Loading interactive chart…
  • GlobeNewswire

    Interpace Biosciences Announces First Quarter 2024 Financial and Business Results

    ●Q1 Revenue of $10.3 million; a 4% increase year-over-year ●Q1 Test volume up 10% year over year to record levels PARSIPPANY, NJ, May 09, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the first quarter ended March 31, 2024 and provided a business and financial update. First quarter Net Revenue was $10.3 million. Operating expenses for the first quarter were approximately 2% lower than the same period of 202

  • GlobeNewswire

    Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results

    ●Q4 and FY Revenue of $10.3 million and $40.2 million; a $8.4 million and 26% increase year-over-year ●Q4 and FY Income from Continuing Operations of $0.8 million and $1.1 million; a $7.0 million and 119% increase year-over-year ●Q4 and FY Adjusted EBITDA of $1.5 million and $5.4 million; a $6.6 million and 463% increase year-over-year ●Q4 and FY Cash collections of $10.2 million and $40.4 million; a $9.0 million and 29% increase year-over-year ●Q4 and FY Volume, Revenue, and Profitability at al

  • GlobeNewswire

    Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results

    ●Q3 Revenue of $9.1 million; an 11% increase year-over-year ●Q3 Test volume up 11% year-over-year ●Q3 Reimbursement improvement up 11% year-over-year, driven by additional commercial contracts and collection initiatives PARSIPPANY, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the third quarter ended September 30, 2023 and provided a business and financial update. Third quarter Net Revenue was